All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia
- 1 January 2001
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 38 (1) , 13-25
- https://doi.org/10.1016/s0037-1963(01)90002-2
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCRLeukemia, 2000
- Presenting White Blood Cell Count and Kinetics of Molecular Remission Predict Prognosis in Acute Promyelocytic Leukemia Treated With All-Trans Retinoic Acid: Result of the Randomized MRC TrialBlood, 1999
- Acute promyelocytic leukemia relapse in the central nervous system during hematologic and molecular remissionAmerican Journal of Hematology, 1999
- Preliminary experience in external quality control of RT-PCR PML-RARα detection in promyelocytic leukemiaLeukemia, 1998
- Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group.Journal of Clinical Oncology, 1998
- Sweet's Syndrome During Treatment with All-Trans Retinoic Acid in a Patient with Acute Promyelocytic LeukemiaLeukemia & Lymphoma, 1998
- Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reactionBlood, 1992
- Hypercalcaemia due to all-trans retinoic acidThe Lancet, 1992
- A Variant Form of Hypergranular Promyelocytic Leukemia (M3)Annals of Internal Medicine, 1980
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976